Targeting vascular endothelial growth factor in angina therapy (Q36379360)

13 August 2017

1 reference

title

Targeting vascular endothelial growth factor in angina therapy (English)

1 reference

13 August 2017

0 references

Munir Boodhwani

1

1 reference

13 August 2017

Basel Ramlawi

series ordinal

2

1 reference

13 August 2017

Roger J Laham

series ordinal

3

1 reference

13 August 2017

Frank W Sellke

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Expert Opinion on Therapeutic Targets

13 August 2017

published in

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

5-14

1 reference

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Influence of internal mammary artery grafting and completeness of revascularization on long-term outcome in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Association between completeness of percutaneous coronary revascularization and postprocedure outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Therapeutic angiogenesis in cardiology using protein formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Optimisation of growth hormone production by muscle cells using plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Effective repeat administration with adenovirus vectors to the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

High throughput production, screening and analysis of adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Dose response to a single intramuscular injection of recombinant adeno-associated virus-erythropoietin in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Design and packaging of adeno-associated virus gene targeting vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Adeno-associated virus site-specifically integrates into a muscle-specific DNA region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Progress with retroviral gene vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Modular retro-vectors for transgenic and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Vectors for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Normalization of coronary microvascular reactivity and improvement in myocardial perfusion by surgical vascular endothelial growth factor therapy combined with oral supplementation of l-arginine in a porcine model of endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14728222.10.1.5

21 January 2018

Identifiers

DOI

10.1517/14728222.10.1.5

1 reference

13 August 2017

1 reference